Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Advocacy at a Glance 11/8/20 Advocacy at a Glance 11/8/20 Advocacy at a Glance Read More
Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
